Alzheimer's Disease clinical trials
Showing 301–331 of 331 active trials. Describe your situation to see which ones you may be eligible for.
- Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
- Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases
- Mid-frontal Delta/Theta and Cognitive Control
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- DECIDE: Dyads and Families
- Phase II Clinical Trial of Interleukin-2 in AD
- A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
- Sensory-Evoked Cortical Gamma Oscillation
- Rapamycin - Effects on Alzheimer's and Cognitive Health
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
- Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
- Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease
- Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
- Pilot Study of a Brain Health Program in Senior Centers
- Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease
- R21 Roche: 3-Way Tau Tracers in AD
- Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
- Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
- Gut Microbiome and Blood Indices in Patients With AD and Their Spousal Caregivers
- Arizona Alzheimer's Disease Research Center (ADRC)
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
- Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
- I-CARE Rural Pilot: Intervention for Rural-Dwelling Dementia Caregivers
- Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
- Emergency Preparedness for Caregivers of Persons With Dementia: Disaster PrepWise
- Systemic and Central Inflammation in AD
- SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden
- The Locus Coeruleus, Norepinephrine and Cognitive Aging
- Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
- LEADing Dementia End-of-Life Planning Conversations
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.